These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19776196)

  • 21. Nasopharyngeal carriage with Streptococcus pneumoniae augments the immunizing effect of pneumolysin toxoid B.
    Neill DR; Smeaton S; Bangert M; Kadioglu A
    J Allergy Clin Immunol; 2013 May; 131(5):1433-5.e1. PubMed ID: 23260752
    [No Abstract]   [Full Text] [Related]  

  • 22. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
    Kuo CY; Hwang KP; Hsieh YC; Cheng CH; Huang FL; Shen YH; Huang YC; Chiu CH; Chen PY; Lin TY
    Vaccine; 2011 Jul; 29(32):5171-7. PubMed ID: 21621578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of carriage and transmission of Streptococcus pneumoniae: the beneficial "side effect" of pneumococcal conjugate vaccine.
    Azzari C; Resti M
    Clin Infect Dis; 2008 Oct; 47(8):997-9. PubMed ID: 18781870
    [No Abstract]   [Full Text] [Related]  

  • 24. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.
    Simell B; Korkeila M; Pursiainen H; Kilpi TM; Käyhty H
    J Infect Dis; 2001 Mar; 183(6):887-96. PubMed ID: 11237805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
    Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
    Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children.
    Xu Q; Casey JR; Almudevar A; Pichichero ME
    Clin Microbiol Infect; 2017 Jul; 23(7):487.e1-487.e6. PubMed ID: 28143785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines.
    Principi N; Esposito S
    Hum Vaccin Immunother; 2015; 11(6):1494-500. PubMed ID: 25970715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and risk factors of nasopharyngeal carriage of Streptococcus pneumoniae in healthy children in Japan.
    Ueno M; Ishii Y; Tateda K; Anahara Y; Ebata A; Iida M; Inamura S; Takahata K; Suzuki Y; Chang B; Wada A; Sugita M; Tanaka T; Nishiwaki Y
    Jpn J Infect Dis; 2013; 66(1):22-5. PubMed ID: 23429080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil.
    Brandileone MC; Zanella RC; Almeida SCG; Brandao AP; Ribeiro AF; Carvalhanas TMP; Sato H; Andrade AL; Verani JR;
    Vaccine; 2016 Nov; 34(46):5604-5611. PubMed ID: 27692770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.
    van Gils EJ; Veenhoven RH; Hak E; Rodenburg GD; Bogaert D; Ijzerman EP; Bruin JP; van Alphen L; Sanders EA
    JAMA; 2009 Jul; 302(2):159-67. PubMed ID: 19584345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation.
    Munoz FM; Englund JA; Cheesman CC; Maccato ML; Pinell PM; Nahm MH; Mason EO; Kozinetz CA; Thompson RA; Glezen WP
    Vaccine; 2001 Dec; 20(5-6):826-37. PubMed ID: 11738746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young children.
    Hagerman A; Posfay-Barbe KM; Grillet S; Ochs MM; Brookes RH; Greenberg D; Givon-Lavi N; Dagan R; Siegrist CA
    Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):43-9. PubMed ID: 22903166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease.
    Mureithi MW; Finn A; Ota MO; Zhang Q; Davenport V; Mitchell TJ; Williams NA; Adegbola RA; Heyderman RS
    J Infect Dis; 2009 Sep; 200(5):783-93. PubMed ID: 19642930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae.
    Kaur R; Surendran N; Ochs M; Pichichero ME
    Infect Immun; 2014 Dec; 82(12):5069-75. PubMed ID: 25245804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine.
    Shahid NS; Steinhoff MC; Hoque SS; Begum T; Thompson C; Siber GR
    Lancet; 1995 Nov; 346(8985):1252-7. PubMed ID: 7475716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
    Dagan R; Givon-Lavi N; Porat N; Greenberg D
    Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction.
    Njuma Libwea J; Gröndahl-Yli-Hannuksela K; Kobela M; Toropainen M; Nyholm O; Ndombo PK; Koulla-Shiro S; Nohynek H; Nuorti JP; Vuopio J; Palmu AA
    Int J Infect Dis; 2020 Sep; 98():113-120. PubMed ID: 32562849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort study.
    Francis JP; Richmond PC; Michael A; Siba PM; Jacoby P; Hales BJ; Thomas WR; Lehmann D; Pomat WS; van den Biggelaar AHJ
    Pneumonia (Nathan); 2016; 8():12. PubMed ID: 28702291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population.
    Carvalho BT; Carneiro-Sampaio MM; Solé D; Naspitz C; Leiva LE; Sorensen RU
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):50-4. PubMed ID: 9874663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines.
    Lu J; Sun T; Hou H; Xu M; Gu T; Dong Y; Wang D; Chen P; Wu C; Liang C; Sun S; Jiang C; Kong W; Wu Y
    Immunol Invest; 2014; 43(7):717-26. PubMed ID: 25020076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.